Study of levels of latamoxef in prostatic tissue and bladder mucosal tissue

The concentration of Latamoxef (LMOX) in the serum, prostatic tissue and bladder mucosal tissue of 20 patients with benign prostatic hypertrophy and bladder cancer was measured after intravenous infusion of 1 g or 2 g of LMOX. Serum, prostatic tissue and bladder mucosal tissue levels of LMOX respond...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 33(1987), 2 vom: 01. Feb., Seite 289-93
1. Verfasser: Nakata, Y (VerfasserIn)
Weitere Verfasser: Mizunaga, M, Morikawa, M, Osanai, H, Fujisawa, M, Inada, F, Yachiku, S
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1987
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Moxalactam VUF6C936Z3
Beschreibung
Zusammenfassung:The concentration of Latamoxef (LMOX) in the serum, prostatic tissue and bladder mucosal tissue of 20 patients with benign prostatic hypertrophy and bladder cancer was measured after intravenous infusion of 1 g or 2 g of LMOX. Serum, prostatic tissue and bladder mucosal tissue levels of LMOX responded satisfactorily to the dose of LMOX. The bladder mucosal tissue level was higher than the prostatic tissue levels. Judging from the inhibitory concentration of LMOX (MIC 80), the concentration was sufficiently effective against infections caused by gram-negative, gram-positive and anaerobic bacilli
Beschreibung:Date Completed 14.07.1987
Date Revised 09.12.2020
published: Print
Citation Status MEDLINE
ISSN:0018-1994